Induction of Neutralizing Antibodies against Diphtheria Toxin by Priming with Recombinant Mycobacterium bovis BCG Expressing CRM(197), a Mutant Diphtheria Toxin
BCG, the attenuated strain of Mycobacterium bovis, has been widely used as a vaccine against tuberculosis and is thus an important candidate as a live carrier for multiple antigens. With the aim of developing a recombinant BCG (rBCG) vaccine against diphtheria, pertussis, and tetanus (DPT), we analy...
שמור ב:
| הוצא לאור ב: | Infect Immun |
|---|---|
| Principais autores: | , , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Society for Microbiology (ASM)
2001
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC97964/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11159980/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/IAI.69.2.869-874.2001 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
